Clinical Trials Logo
  1. Home
  2. Cancer of Prostate
  3. NCT02235142

Prostatic Cancer Versus Androgen Deficiency — AndroCan  

Cancer of Prostate Clinical Trial

Official title:
Localised Cancer of Prostate and Androgen Deficiency.

Clinical Trial Summary

Open study to make a comparison between hypogonadism and euogonadism patients regarding the severity of prostate cancer. The purpose of this study is to determine the importance of the relationship between the hormonal status and the type of the tumor at the time of surgical intervention as well as follow up of the patients.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT02235142
Study type Interventional
Source Hopital Foch
Contact
Status Completed
Phase N/A
Start date June 3, 2013
Completion date December 22, 2021
View Details
See also
  Status Clinical Trial Phase
Withdrawn NCT05191017 - Study of NUV-422 in Combination With Enzalutamide in Patients With mCRPC Phase 1/Phase 2
Completed NCT00970203 - Dendritic Cell (DC)-Based Vaccines Loaded With Allogeneic Prostate Cell Lines in Combination With Androgen Ablation in Patients With Prostate Cancer Phase 2
Completed NCT03031418 - Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
Completed NCT01639859 - Assessment of Supersonic Imagine Aixplorer for the Detection and Localisation of Prostate Cancer Foci N/A
Completed NCT02362464 - Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 Phase 2
Enrolling by invitation NCT05844761 - Real-time Motion Management During Prostate and Lung Radiotherapy N/A
Completed NCT03442075 - Pain Comparison Whit Visual Analog Scale (EVA) Between Four Analgesic Methods During Trans Rectal Prostatic Biopsy
Recruiting NCT05252390 - NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors Phase 1/Phase 2
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Completed NCT03444532 - Feasibility Study Testing a Sleep Intervention in Prostate Cancer Patients With Insomnia N/A
Recruiting NCT05600400 - Improving Sexual Quality of Life - Randomized Trial of Two vs Five MRI Guided SABR Treatments for Prostate Cancer N/A
Not yet recruiting NCT05653063 - ARCHERY - Artificial Intelligence Based Radiotherapy Treatment Planning for Cervical, Head and Neck and Prostate Cancer
Recruiting NCT06318559 - Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention N/A
Completed NCT01477749 - Sipuleucel-T Manufacturing Demonstration Study Phase 2
Active, not recruiting NCT03632980 - Dynamic Focusing Evaluation for Prostate Cancer Treatment N/A
Recruiting NCT04319783 - Darolutamide + Consolidation Radiotherapy in Advanced Prostate Cancer Detected by PSMA Phase 2
Recruiting NCT04258813 - Onco-primary Care Networking to Support TEAM-based Care N/A
Recruiting NCT05361798 - T-Cell Clonality After Stereotactic Body Radiation Therapy Alone and in Combination With the Immunocytokine M9241 in Localized High- and Intermediate-Risk Prostate Cancer Treated With Androgen Deprivation Therapy Phase 2
Completed NCT04304196 - Tailored, wEb-based, Psychosocial and Physical Activity Self-Management PrOgramme N/A
Completed NCT02564120 - North Carolina Prostate Cancer Comparative Effectiveness & Survivorship Study (NC ProCESS)